BrightPath Biotherapeutics Co.Ltd.'s total assets for Q3 2023 were ¥1.43B, an increase of 22.76% from the previous quarter. JP:4594 total liabilities were ¥655.82M for the fiscal quarter, a 337.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.